Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma

Aim: Cutaneous T-cell lymphoma (CTCL) is a group of T-cell malignancies that develop in the skin. Though studied intensively, the etiology and pathogenesis of CTCL remain elusive. This study evaluated the survival of CTCL patients in the 1st Department of Dermatovenereology of St. Anne’s University...

Full description

Bibliographic Details
Main Authors: Vladimír Vašků, Jan Máchal, Filip Zlámal, Anna Vašků
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/13/12/2401
_version_ 1797457703656751104
author Vladimír Vašků
Jan Máchal
Filip Zlámal
Anna Vašků
author_facet Vladimír Vašků
Jan Máchal
Filip Zlámal
Anna Vašků
author_sort Vladimír Vašků
collection DOAJ
description Aim: Cutaneous T-cell lymphoma (CTCL) is a group of T-cell malignancies that develop in the skin. Though studied intensively, the etiology and pathogenesis of CTCL remain elusive. This study evaluated the survival of CTCL patients in the 1st Department of Dermatovenereology of St. Anne’s University Hospital Brno. It included analysis of 19 polymorphic gene variants based on their expected involvement in CTCL severity. Material and methods: 75 patients with CTCL, evaluated and treated at the 1st Department of Dermatovenereology of St. Anne´s University Hospital Brno, Faculty of Medicine, Masaryk University, were recruited for the study over the last 28 years (44 men and 31 women, average age 58 years, range 20–82 years). All patients were genotyped for 19 chosen gene polymorphisms by the conventional PCR method with restriction analysis. A multivariate Cox regression model was calculated to reveal genetic polymorphisms and other risk factors for survival. Results: The model identified MDR Ex21 2677 (rs2032582) as a significant genetic factor influencing the survival of the patients, with the T-allele playing a protective role. A multivariate stepwise Cox regression model confirmed the following as significant independent risk factors for overall survival: increased age at admission, clinical staging of the tumor, and male sex. Conclusion: We showed that the TT genotype at position 2677 of the MDR1 gene exhibited statistically significant longer survival in CTCL patients. As such, the TT genotype of MDR1 confers a significant advantage for the CTCL patients who respond to treatment.
first_indexed 2024-03-09T16:27:40Z
format Article
id doaj.art-a260e75e930948959a6bc49c64cd3d63
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-09T16:27:40Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-a260e75e930948959a6bc49c64cd3d632023-11-24T15:06:22ZengMDPI AGGenes2073-44252022-12-011312240110.3390/genes13122401Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell LymphomaVladimír Vašků0Jan Máchal1Filip Zlámal2Anna Vašků31st Department of Dermatovenereology, St. Anne’s University Hospital, Faculty of Medicine, Masaryk University, 65691 Brno, Czech RepublicDepartment of Pathological Physiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech RepublicDepartment of Pathological Physiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech RepublicDepartment of Pathological Physiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech RepublicAim: Cutaneous T-cell lymphoma (CTCL) is a group of T-cell malignancies that develop in the skin. Though studied intensively, the etiology and pathogenesis of CTCL remain elusive. This study evaluated the survival of CTCL patients in the 1st Department of Dermatovenereology of St. Anne’s University Hospital Brno. It included analysis of 19 polymorphic gene variants based on their expected involvement in CTCL severity. Material and methods: 75 patients with CTCL, evaluated and treated at the 1st Department of Dermatovenereology of St. Anne´s University Hospital Brno, Faculty of Medicine, Masaryk University, were recruited for the study over the last 28 years (44 men and 31 women, average age 58 years, range 20–82 years). All patients were genotyped for 19 chosen gene polymorphisms by the conventional PCR method with restriction analysis. A multivariate Cox regression model was calculated to reveal genetic polymorphisms and other risk factors for survival. Results: The model identified MDR Ex21 2677 (rs2032582) as a significant genetic factor influencing the survival of the patients, with the T-allele playing a protective role. A multivariate stepwise Cox regression model confirmed the following as significant independent risk factors for overall survival: increased age at admission, clinical staging of the tumor, and male sex. Conclusion: We showed that the TT genotype at position 2677 of the MDR1 gene exhibited statistically significant longer survival in CTCL patients. As such, the TT genotype of MDR1 confers a significant advantage for the CTCL patients who respond to treatment.https://www.mdpi.com/2073-4425/13/12/2401skin T-cell lymphomamycosis fungoidesCTCLpolymorphism-MDR1
spellingShingle Vladimír Vašků
Jan Máchal
Filip Zlámal
Anna Vašků
Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma
Genes
skin T-cell lymphoma
mycosis fungoides
CTCL
polymorphism-MDR1
title Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma
title_full Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma
title_fullStr Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma
title_full_unstemmed Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma
title_short Some New Aspects of Genetic Variability in Patients with Cutaneous T-Cell Lymphoma
title_sort some new aspects of genetic variability in patients with cutaneous t cell lymphoma
topic skin T-cell lymphoma
mycosis fungoides
CTCL
polymorphism-MDR1
url https://www.mdpi.com/2073-4425/13/12/2401
work_keys_str_mv AT vladimirvasku somenewaspectsofgeneticvariabilityinpatientswithcutaneoustcelllymphoma
AT janmachal somenewaspectsofgeneticvariabilityinpatientswithcutaneoustcelllymphoma
AT filipzlamal somenewaspectsofgeneticvariabilityinpatientswithcutaneoustcelllymphoma
AT annavasku somenewaspectsofgeneticvariabilityinpatientswithcutaneoustcelllymphoma